All Categories

To be an Agent

Dasatinib monohydrate

Target Country: France Germany Switzerland

Inquiry: 0

Post Date: 2016-11-23

Valid to: 2017-04-10

Dasatinib is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the "Philadelphia chromosome") and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML)[1] and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). If there is any manufacturer need to sell this product in European countries, please contact me.

  • Gold Member
  • Ddu Verified
    Ddu Verified
    Qualification Approval
Contact Now

Go to Page